📣Instat followers - we are pleased to announce that Instat Clinical Research is now part of Veristat. To stay up-to-date with the latest news and updates, make sure to follow Veristat's LinkedIn 👇 https://bit.ly/4bPjK2j
Instat is now Veristat’s Post
More Relevant Posts
-
I am very proud of our team for accomplishing this. Connecting #RWD to the clinical and operational data we collect enables a stronger understanding of how participants respond to care. Access to medical information isn’t optional - it’s necessary and this provides that pathway towards precision care our industry sorely needs. Let’s go! #patientfirst, #humancentered, #simplybetterdata
Excited to announce our partnership between THREAD and SEQSTER. This collaboration provides a streamlined solution to integrate primary study data, captured on THREAD's platform, with real world data via SEQSTER’s patient-centric Operating System. Expanding data with RWD is key to helping determine the impact of new medicines and aims to accelerate drug development overall. Read the full press release: https://lnkd.in/gzbBkzg9 #clinicalresearch #realworlddata #clinicaltrials
THREAD and SEQSTER Partner to Fast-Track Real World Data Collection for Patients and Researchers
threadresearch.com
-
Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial https://t.co/N0OfdsUWpA #EurekaMag
Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial
eurekamag.com
-
🔍 Unlock Clinical Trials' Best-Kept Secrets with Monocl ExpertInsight! 🚀 Hey Clinical Innovators, ready to turn the tables on your trials? 🌟 Monocl ExpertInsight is your secret weapon! Discover the key and principal investigators behind groundbreaking clinical trials and the 🏥 top-notch trial sites making waves. 🌐 Connect with the "who's who" in clinically related activity. 📈 Make data-driven decisions to ace your clinical phases. 🌟 Pinpoint prime trial sites for success and boost patient recruitment 🕵️♀️ Uncover groundbreaking clinical trials and connect with top investigators 🌐 Gain access to experts across all therapeutic areas, all diseases, and all geographies 🔑 Identify Key Opinion Leaders and industry-sponsored trials Don't just follow the trail, lead it! Let's chat and revolutionize your clinical journey. 🚀 #ClinicalTrials #ExpertInsight #GameChanger #Monocl #Biopharma #Biotech #Pharma #Clinical #Ai #MachineLearning #ClinicalAffairs #ClinicalDevelopment #KOL #KeyOpinionLeaders #KeyInvestigators
-
🌟 Exciting Progress Update from AVITHRAPID! 🌟 We're making strides in our mission to develop antivirals that can combat pandemic infectious diseases. Here’s how our specialized Work Packages (WPs) each play a pivotal role: 🔬 WP1 - Pre-Clinical Discovery and Medicinal Chemistry: This is where our journey begins. Our talented scientists are focused on the discovery of new antiviral compounds, ensuring a solid foundation for breakthrough treatments. 🔍 WP2 - Pre-Clinical Development: Taking discoveries from WP1 forward, WP2 is where these compounds undergo rigorous development processes to prepare for human trials. 🏥 WP3 - Clinical Development: This critical phase involves translating our pre-clinical successes into potential treatments through clinical trials, moving us closer to real-world impact. 💻 WP4 - In Silico Resources: Utilizing advanced computational models, this team simulates drug interactions to predict effectiveness and optimize formulations. 🧪 WP5 - Formulation and Delivery: Innovation continues as we develop safe and effective delivery methods for our potential drugs, ensuring they can reach those in need exactly as intended. 🌍 WP6 - Dissemination, Patient Outreach & Sustainability: Communication is key, and WP6 ensures our findings and progress are shared widely and responsibly, supporting sustainable health outcomes. 📊 WP7 - FAIR Data Management: Upholding the principles of findable, accessible, interoperable, and reusable data, this package supports all other WPs by managing data efficiently. 📝 WP8 - Project Management: The glue that holds our project together, ensuring all teams are aligned, focused, and driven towards our common goal. Through these dedicated teams and their collective efforts, AVITHRAPID is paving the way towards a safer future with innovative healthcare solutions. Stay tuned for more updates as we advance towards our goals. #AVITHRAPID #HealthcareInnovation #DrugDevelopment #TeamScience #EpidemicPreparedness #ClinicalTrials #InnovativeHealth
-
-
Bredec Group BredecDevelopment The uses and benefits of artificial intelligence in clinical trials - Appinventiv: The uses and benefits of artificial intelligence in clinical trials Appinventiv inquiry@bredec.com Inquiry@bredec.com
Google News
appinventiv.com
-
Just launched! Let’s hear from you! 🙌 Whoa, this is groundbreaking! What is the Patient Experience & Program Study? The first of its kind, it is a patient and supporter-led research project with oversight from a Community Advisory Committee. The goal to understand both met and unmet program needs as it relates to your experience. A third party consultant is leading this and all data will be anonymized. Why does this research matter? As people with Narcolepsy or Idiopathic Hypersomnia, you come from many different backgrounds. Your experience will be different from others. Your needs vary depending on where you are in your journey, your age, where you live, and your own unique circumstance. The findings and aggregated themes of the study will be reflected in a final Public Summary Report. What do we want to understand? We want to know how existing programs help you or what others might be offered to better serve you. Your opinions matter. Where are you in your journey with narcolepsy or idiopathic hypersomnia? What kinds of education, support, or advocacy programs help you? Are there other programs that are needed to best serve you? 💭 To participate, click here: https://ow.ly/RuZR50Sg8Wp ⭐ Thank you to our sponsors*: Avadel Pharmaceuticals, Harmony Biosciences, Jazz Pharmaceuticals, Takeda Pharmaceuticals, and Zevra Therapeutics. *Note: Sponsors are not involved in developing Study scope, format, or protocols, and will not have access to confidential data or patient information. #NarcolepsyNetwork #narcolepsy #idiopathichypersomnia #sleepdisorder #research #programs
-
-
R&D, Drug Development & Medical Affairs, Market Access Global Clinical Studies and Product Lifecycle Management, RA, Board of Directors, International Speaker, Development Programs, Strategic Leadership.
overview on different type of sources, like #claims, #registries, #EHRs, etc. known limitations we have with #RWD, structured vs unstructured data, etc. focus on the quantification of #dataquality #realworlddata #RWE
My dear colleague Kerem Organ from Gilead Sciences shared the attached paper that is discussing #RWD sources in Oncology. I must admit that there are numerous data solutions in the space of #Oncology / #Haematology, many more than in other therapeutic areas (TAs). The authors give an overview on different type of sources, like #claims, #registries, #EHRs, etc. They are also discussing known limitations we have with #RWD, structured vs unstructured data, etc. However, their focus is on the quantification of #data_quality & they suggest three components: - “Fitness for purpose” that is related to fit for purpose data, in terms of addressing the scientific gaps of interest, have sufficient follow-up period and low rates of missingness; - “Data provenance” associated to data characteristics and data management protocols that provide details on multiple steps used during the collection, curation, transformation of real data, particularly from unstructured notes; furthermore, geographical coverage, and how patients are moving in- and out- the databases is of high importance too; - “Scientific interest and RWE studies” in terms of conducting observational research that is relevant to the scientific world and of great interest to decision makers; such studies could be those addressing comparative evidence, predictors of outcomes, disparities, evaluation of policies, etc; The authors conclude this work by appraising the value of #RWE when is used to help HCPs to make informed decisions, in the identification of higher value subgroups, estimation of casual links & in the development of therapeutic solutions that improve further patient care and ouctomes. Many thx to Kerem Organ for sharing this article with us. Disclaimer: The opinions shared are solely my own and do not express the views or opinions of any of my employers.
-
Introducing, MetX. The very foundation of the Metrodora mission consists of bringing together patients, providers, and scientists. Each entity holds a key to unlocking the answers behind complex illnesses. We knew the silos of medicine were hindering advancement, so we set out to try something different. Disrupting an entire industry takes time our patients don’t have. Symptoms are often derailing their dreams in the prime of their lives. We knew we had to work hard and fast. Since opening our doors a year ago, our team has seen hundreds of patients, launched clinical trials, and now we are excited to announce MetX, funded by a grant from the Metrodora Foundation and our visionary donors. This is how we come together to accelerate research, treatment, and cures. Patients are empowered to become partners through Metrodora Connect, a digital health toolkit where sharing health records, questionnaires, and wearable device data means an active role in research. A biorepository will host specimens to advance genetic, antibody, and cellular treatments. While leveraging partnerships with other major medical research organizations, Metrodora Biomics will use these specimens to discover targeted drug therapies. The tools, people, and passion already exist. It’s time they unite. We invite you to get to know MetX and the possibilities for all to make a difference right now. #MetX #MetrodoraFoundation #MetrodoraInstitute #Metrodora #MedicalNews #Medical #Medicine #Healthcare #Research #ComplexIllness #LongCOVID #MECFS #POTS #Migraine #Sjogrens #EDS #MCAS #ChronicPain #Fibromyalgia #Endometriosis #FoodAllergy #IBS #IBD
Announcing Met X: The Next Step in Understanding Chronic, Complex Conditions
metrodora.org
-
Everything Data at Oakland ⭕ | Mental Health First Aider 💚 | Street Photographer 📸 | PADI Advanced Open Water Diver 🤿
Great article by Greg Killian at EPAM Systems discussing the benefits of open-source technologies for clinical trials. Open-source software is an enabler for innovation and allows users to customise it to meet their individual needs. This can be seen back in 2019 when Insilico Medicine (Alex Zhavoronkov) used the AI-powered GENTRL system for drug discovery and created 6 new molecules to address diseases such as fibrosis. GENTRL is available as open-source and Insilico Medicine is leading the charge for innovation in this space, allowing it to become more accessible for the public. What other open-source technologies are you aware of that could benefit the industry and the public? #opensourcesoftware #opensourcelifescience #epamsystems #insilicomedicine #drugdiscovery
How Open-Source Benefits Clinical Trials
pharmexec.com
-
📣 Join us in Philadelphia on September 25-27, 2024 for this thought-provoking keynote, Modernizing Clinical Trials for the Next Era of Drug Development. Bari Kowal from Regeneron will examine important topics facing clinical professionals including the role of AI in clinical development, modernizing trial design to drive efficiencies, utilizing digital health technologies to enhance clinical data collection and the promise of genetic medicines and what it means for the future of clinical trials. Register now and save up to $700 with the Super Early Bird Rate before May 24th with Promo Code SUPER. https://lnkd.in/g28sd8p4 #FierceClinicalSummit #WeAreFierce #FierceBiotech #FiercePharma #ClinicalResearch #ClinicalTrials #TrialOptimization #ClinicalOperations #ClinicalQuality #ClinicalData #ClinicalTrialConference #ClinicalTrialOversight #ClinicalDataManagement
-
